Defining and maintaining a high quality screening collection: the GSK experience

Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. This article out...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug discovery today 2006-03, Vol.11 (5-6), p.267-272
Hauptverfasser: Lane, Stephen J., Eggleston, Drake S., Brinded, Keith A., Hollerton, John C., Taylor, Nicholas L., Readshaw, Simon A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. This article outlines how this issue was approached at GlaxoSmithKline and some of the hurdles that needed to be overcome to achieve success. The article focuses specifically on the necessary software and hardware infrastructure needed, and at some of the extra benefits of such a project in terms of data mining and data modelling.
ISSN:1359-6446
1878-5832
DOI:10.1016/S1359-6446(05)03730-X